{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:52:43Z","timestamp":1785840763138,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T00:00:00Z","timestamp":1429315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10620-015-3655-3","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T01:40:19Z","timestamp":1429234819000},"page":"1948-1957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis"],"prefix":"10.1007","volume":"60","author":[{"given":"YinHua","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YingYing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YongGuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiJun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,18]]},"reference":[{"key":"3655_CR1","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.3748\/wjg.14.3937","volume":"14","author":"PL Lakatos","year":"2008","unstructured":"Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol. 2008;14:3937\u20133947.","journal-title":"World J Gastroenterol"},{"key":"3655_CR2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ng.549","volume":"42","author":"DP McGovern","year":"2010","unstructured":"McGovern DP, Gardet A, Torkvist L, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet. 2010;42:332\u2013337.","journal-title":"Nat Genet"},{"key":"3655_CR3","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.","journal-title":"Genome Biol"},{"key":"3655_CR4","first-page":"357","volume":"14","author":"CM Preda","year":"2005","unstructured":"Preda CM, Vermeire S, Rutgeerts P, et al. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn\u2019s disease and ulcerative colitis. Rom J Gastroenterol. 2005;14:357\u2013360.","journal-title":"Rom J Gastroenterol"},{"key":"3655_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cellimm.2007.02.004","volume":"244","author":"EC Ebert","year":"2006","unstructured":"Ebert EC, Geng X, Lin J, et al. Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis. Cell Immunol. 2006;244:43\u201349.","journal-title":"Cell Immunol"},{"key":"3655_CR6","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/ajg.2009.455","volume":"104","author":"EC Ebert","year":"2009","unstructured":"Ebert EC, Geng X, Bajpai M, et al. Antibody to tropomyosin isoform 5 and complement induce the lysis of colonocytes in ulcerative colitis. Am J Gastroenterol. 2009;104:2996\u20133003.","journal-title":"Am J Gastroenterol"},{"key":"3655_CR7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/gut.2010.217117","volume":"60","author":"C Veltkamp","year":"2011","unstructured":"Veltkamp C, Anstaett M, Wahl K, et al. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFalpha treatment. Gut. 2011;60:1345\u20131353.","journal-title":"Gut"},{"key":"3655_CR8","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/mi.2008.40","volume":"1","author":"IJ Fuss","year":"2008","unstructured":"Fuss IJ, Strober W. The role of IL-13 and NK T cells in experimental and human ulcerative colitis. Mucosal Immunol. 2008;1:S31\u2013S33.","journal-title":"Mucosal Immunol"},{"key":"3655_CR9","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.2174\/138161209788489113","volume":"15","author":"J Nishihira","year":"2009","unstructured":"Nishihira J, Mitsuyama K. Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel disease. Curr Pharm Des. 2009;15:2104\u20132109.","journal-title":"Curr Pharm Des"},{"key":"3655_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2010.03.004","volume":"136","author":"M Martinesi","year":"2010","unstructured":"Martinesi M, Treves C, Bonanomi AG, et al. Down-regulation of adhesion molecules and matrix metalloproteinases by ZK 156979 in inflammatory bowel diseases. Clin Immunol. 2010;136:51\u201360.","journal-title":"Clin Immunol"},{"key":"3655_CR11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-230X-11-138","volume":"11","author":"F Sanchez-Munoz","year":"2011","unstructured":"Sanchez-Munoz F, Fonseca-Camarillo G, Villeda-Ramirez MA, et al. Transcript levels of Toll-Like receptors 5, 8 and 9 correlate with inflammatory activity in ulcerative colitis. BMC Gastroenterol. 2011;11:138.","journal-title":"BMC Gastroenterol"},{"key":"3655_CR12","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1524-475X.2007.00221.x","volume":"15","author":"Y Wu","year":"2007","unstructured":"Wu Y, Wang J, Scott PG, et al. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen. 2007;15:S18\u2013S26.","journal-title":"Wound Repair Regen"},{"key":"3655_CR13","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","volume":"134","author":"TK Kuo","year":"2008","unstructured":"Kuo TK, Hung SP, Chuang CH, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008;134:2111\u20132121.","journal-title":"Gastroenterology"},{"key":"3655_CR14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1124\/jpet.108.137083","volume":"326","author":"Y Hayashi","year":"2008","unstructured":"Hayashi Y, Tsuji S, Tsujii M, et al. Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J Pharmacol Exp Ther. 2008;326:523\u2013531.","journal-title":"J Pharmacol Exp Ther"},{"key":"3655_CR15","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1007\/s10620-012-2290-5","volume":"57","author":"XW He","year":"2012","unstructured":"He XW, He XS, Lian L, et al. Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice. Dig Dis Sci. 2012;57:3136\u20133144.","journal-title":"Dig Dis Sci"},{"key":"3655_CR16","first-page":"10","volume":"84","author":"LB Lazebnik","year":"2012","unstructured":"Lazebnik LB, Knyazev OV, Parfenov AI, et al. Optimization of cell therapy in patients with inflammatory bowel diseases. Ter Arkh. 2012;84:10\u201317.","journal-title":"Ter Arkh"},{"key":"3655_CR17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc2843","volume":"10","author":"D Metcalf","year":"2010","unstructured":"Metcalf D. The colony-stimulating factors and cancer. Nat Rev Cancer. 2010;10:425\u2013434.","journal-title":"Nat Rev Cancer"},{"key":"3655_CR18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2036.2006.03016.x","volume":"24","author":"MW Harbord","year":"2006","unstructured":"Harbord MW, Marks DJ, Forbes A, et al. Impaired neutrophil chemotaxis in Crohn\u2019s disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor. Aliment Pharmacol Ther. 2006;24:651\u2013660.","journal-title":"Aliment Pharmacol Ther"},{"key":"3655_CR19","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1084\/jem.20091233","volume":"206","author":"AM Smith","year":"2009","unstructured":"Smith AM, Rahman FZ, Hayee B, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn\u2019s disease. J Exp Med. 2009;206:1883\u20131897.","journal-title":"J Exp Med"},{"key":"3655_CR20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1084\/jem.20091683","volume":"206","author":"JL Casanova","year":"2009","unstructured":"Casanova JL, Abel L. Revisiting Crohn\u2019s disease as a primary immunodeficiency of macrophages. J Exp Med. 2009;206:1839\u20131843.","journal-title":"J Exp Med"},{"key":"3655_CR21","doi-asserted-by":"crossref","first-page":"362536","DOI":"10.1155\/2012\/362536","volume":"2012","author":"A Motavallian","year":"2012","unstructured":"Motavallian A, Minaiyan M, Rabbani M, et al. Does cisapride, as a 5HT4 receptor agonist, aggravate the severity of TNBS-induced colitis in rat? Gastroenterol Res Pract. 2012;2012:362536.","journal-title":"Gastroenterol Res Pract"},{"key":"3655_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2010.10.030","volume":"651","author":"M Zhang","year":"2011","unstructured":"Zhang M, Long Y, Sun Y, et al. Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing berberine, hypaconitine and skimmianine on the ulcerative colitis rats induced by trinitrobenzene-sulfonic acid. Eur J Pharmacol. 2011;651:187\u2013196.","journal-title":"Eur J Pharmacol"},{"key":"3655_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(00)00914-6","volume":"411","author":"X Guo","year":"2001","unstructured":"Guo X, Liu ES, Ko JK, et al. Protective role of cyclooxygenase inhibitors in the adverse action of passive cigarette smoking on the initiation of experimental colitis in rats. Eur J Pharmacol. 2001;411:193\u2013203.","journal-title":"Eur J Pharmacol"},{"key":"3655_CR24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1124\/jpet.109.158022","volume":"331","author":"X Deng","year":"2009","unstructured":"Deng X, Tolstanova G, Khomenko T, et al. Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine. J Phamracol Exp Ther. 2009;331:1071\u20131078.","journal-title":"J Phamracol Exp Ther"},{"key":"3655_CR25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1023\/B:DDAS.0000026298.72088.f7","volume":"49","author":"T Vowinkel","year":"2004","unstructured":"Vowinkel T, Kalogeris TJ, Mori M, et al. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig Dis Sci. 2004;49:556\u2013564.","journal-title":"Dig Dis Sci"},{"key":"3655_CR26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0016-5085(90)90280-E","volume":"98","author":"RN Fedorak","year":"1990","unstructured":"Fedorak RN, Empey LR, MacArthur C, et al. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology. 1990;98:615\u2013625.","journal-title":"Gastroenterology"},{"key":"3655_CR27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2141.1998.01059.x","volume":"103","author":"A Kashyap","year":"1998","unstructured":"Kashyap A, Forman SJ. Autologous bone marrow transplantation for non-Hodgkin\u2019s lymphoma resulting in long-term remission of coincidental Crohn\u2019s disease. Br J Haematol. 1998;103:651\u2013652.","journal-title":"Br J Haematol"},{"key":"3655_CR28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1053\/j.gastro.2007.01.064","volume":"132","author":"M Brittan","year":"2007","unstructured":"Brittan M, Alison MR, Schier S, et al. Bone marrow stem cell-mediated regeneration in IBD: where do we go from here? Gastroenterology. 2007;132:1171\u20131173.","journal-title":"Gastroenterology"},{"key":"3655_CR29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000338134","volume":"30","author":"E Ricart","year":"2012","unstructured":"Ricart E. Current status of mesenchymal stem cell therapy and bone marrow transplantation in IBD. Dig Dis (Basel, Switz). 2012;30:387\u2013391.","journal-title":"Dig Dis (Basel, Switz)"},{"key":"3655_CR30","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/eji.1830270722","volume":"27","author":"MF Neurath","year":"1997","unstructured":"Neurath MF, Fuss I, Pasparakis M, et al. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol. 1997;27:1743\u20131750.","journal-title":"Eur J Immunol"},{"key":"3655_CR31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm0996-998","volume":"2","author":"MF Neurath","year":"1996","unstructured":"Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996;2:998\u20131004.","journal-title":"Nat Med"},{"key":"3655_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/B978-0-12-800267-4.00005-5","volume":"122","author":"DS Shouval","year":"2014","unstructured":"Shouval DS, Ouahed J, Biswas A, et al. Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. Adv Immunol. 2014;122:177\u2013210.","journal-title":"Adv Immunol"},{"key":"3655_CR33","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.imbio.2013.04.020","volume":"218","author":"UP Singh","year":"2013","unstructured":"Singh UP, Singh NP, Guan H, et al. Leptin antagonist ameliorates chronic colitis in IL-10\u2212\/\u2212 mice. Immunobiology. 2013;218:1439\u20131451.","journal-title":"Immunobiology"},{"key":"3655_CR34","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3109\/00365529008998554","volume":"25","author":"VS Chadwick","year":"1990","unstructured":"Chadwick VS, Schlup MM, Ferry DM, et al. Measurements of unsaturated vitamin B12-binding capacity and myeloperoxidase as indices of severity of acute inflammation in serial colonoscopy biopsy specimens from patients with inflammatory bowel disease. Scand J Gastroenterol. 1990;25:1196\u20131204.","journal-title":"Scand J Gastroenterol"},{"key":"3655_CR35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2739\/kurumemedj.45.69","volume":"45","author":"T Saiki","year":"1998","unstructured":"Saiki T. Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease. Kurume Med J. 1998;45:69\u201373.","journal-title":"Kurume Med J"},{"key":"3655_CR36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7\u201311.","journal-title":"J Clin Invest"},{"key":"3655_CR37","first-page":"208","volume":"41","author":"YJ Chang","year":"2009","unstructured":"Chang YJ, Huang XJ. Immune tolerance induced by cytokines in allogeneic hematopoietic stem cell transplantation. Beijing Da Xue Xue Bao. 2009;41:208\u2013211.","journal-title":"Beijing Da Xue Xue Bao"},{"key":"3655_CR38","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M Nicola Di","year":"2002","unstructured":"Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838\u20133843.","journal-title":"Blood"},{"key":"3655_CR39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1043-4666(03)00149-2","volume":"23","author":"H Egi","year":"2003","unstructured":"Egi H, Hayamizu K, Yoshimitsu M, et al. Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor. Cytokine. 2003;23:23\u201330.","journal-title":"Cytokine"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3655-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-3655-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3655-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:49:50Z","timestamp":1559231390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-3655-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,18]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["3655"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-3655-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,18]]}}}